Skip to main content

Scientists Estimate Zika-Related Microcephaly Risk

A fetus whose mother is infected with Zika during the first trimester of her pregnancy has a risk of between 1 percent and 13 percent of developing microcephaly, according to a study.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

A baby with microcephaly (left) compared to a baby with a typical-sized head (right)WIKIMEDIA, CDCAn analysis published this week (May 25) in The New England Journal of Medicine has quantified the estimated risk of microcephaly in the developing fetuses of pregnant women infected with Zika virus. Using data from the Zika-hit state of Bahia in Brazil, researchers estimated the risk of microcephaly when mothers were infected during the first trimester of pregnancy to be between 1 percent and 13 percent.

“It is an appreciable risk,” study coauthor Michael Johansson of the US Centers for Disease Control and Prevention (CDC) told The Washington Post. “We need to do whatever we can to help women avoid Zika virus infections during pregnancy.”

In April, the CDC declared that sufficient evidence had accumulated to support a causal link between Zika virus infection and microcephaly and other birth defects; a study published earlier this month provided further support for the link, showing that the virus could cause microcephaly and other defects in developing mouse embryos. However, the present study is one of the first to provide a quantitative estimate of an infant’s risk of microcephaly following maternal infection.

This estimate is the result of an analysis of Zika virus infection ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays